Citation 38430

TAKECHI,M: TANAKA,Y:. (1987). BINDING OF 1,2,3,4,6-PENTAGALLOYLGLUCOSE TO PROTEINS, LIPIDS, NUCLEIC ACIDS AND SUGARS.. 26(1)

Citation Details

TitleBINDING OF 1,2,3,4,6-PENTAGALLOYLGLUCOSE TO PROTEINS, LIPIDS, NUCLEIC ACIDS AND SUGARS.
AuthorsTAKECHI,M: TANAKA,Y:
Year1987
Volume26
Issue1

Summary

Year: 1987

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
2
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
3
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
4
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
5
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
6
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
7
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
8
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
9
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
10
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
11
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
12
PROTEIN BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
13
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
14
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
15
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
16
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
17
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
18
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
19
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
20
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
21
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
22
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
23
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
24
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
25
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
26
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
27
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
28
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
29
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
30
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
31
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
32
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
33
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
34
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
35
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
36
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
37
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
38
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
39
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
40
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
41
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
42
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
43
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
44
BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
EQUIVOCAL
45
DNA BINDING EFFECT
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
46
RNA BINDING
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-BETA-D-GLUCOSE,1-2-3-4-6-PENTA-O:
ACTIVE
Show SPARQL Queries (1)